Auven Therapeutics Company Profile

21:11 EST 18th January 2017 | BioPortfolio

Auven Therapeutics is a private equity company focused on the healthcare industry.

The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. The value of these therapeutic assets is then significantly enhanced by global development programs prior to selling them as clinically and commercially validated products to established pharmaceutical companies.

Auven Therapeutics has built a diversified portfolio of biologic and small molecule therapeutic candidates for a wide range of therapeutic indications. The Company’s existing pipeline addresses critical unmet medical needs in cancer, ophthalmic conditions, women’s health and orphan diseases.

It has ownership of or a controlling interest in the therapeutic assets of ADC Therapeutics, Spirogen, Resolvyx and Kiacta, and a minority investment in Kolltan and Sprout Pharmaceuticals.

Founded in 2007 by industry veterans Stephen Evans-Freke and Dr. Peter B. Corr, Auven Therapeutics Management L.L.L.P. is an investment advisor with its principal place of business in the US Virgin Islands. It manages Auven Therapeutics Holdings L.P., a private equity fund, which has its registered office and principal place of business in the British Virgin Islands. Auven Therapeutics Development, the operating company of Auven Therapeutics Holdings L.P. manages drug development from its bases in Lausanne, Switzerland, New York, USA and Hamilton, Bermuda.


6501 Redhook Plaza, Suite 201
St. Thomas


Phone: +1-340-779-6908 (phone)
Fax: +1-340-714-5192 (fax)

News Articles [1866 Associated News Articles listed on BioPortfolio]

Auven Therapeutics completes enrollment in phase 3 study of Seciera for dry eye

Auven Therapeutics completed enrollment in a phase 3 confirmatory study of Seciera for the treatment of dry eye disease, according to a press release.Seciera (OTX-101) is a novel patented nanomicellar...

Auven to Sell Subsidiary, Dry Eye Disease Candidate to Sun Pharma

Auven Therapeutics said today it will sell its Ocular Technologies subsidiary—whose key asset is the Phase III dry eye disease treatment candidate Seciera TM (OTX-101)—to Sun Pharma for $40 millio...

After Failed Phase III, Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) to Terminate the KIACTA Program

  Life Sciences Jobs   ...

BRIEF-Auven Therapeutics announces sale of Ocular Technologies to Sun Pharma

* Auven Therapeutics announces sale of Ocular Technologies to Sun Pharma

ADC Therapeutics closes $105mm third round

ADC Therapeutics SARL raised $105mm through its third funding round from new and returning investors including Auven Therapeutics and AstraZeneca. The company, which is developing antibody-drug conjug...

BRIEF-Bellus Health provides update on pipeline

* Auven Therapeutics has decided to terminate Kiacta program for treatment of AA Amyloidosis

Ep. 34: Versant closes oversubscribed sixth healthcare-focused fund

Versant Ventures closes its newest fund, a new stem cell company is born in the MaRs Discovery District and Auven Therapeutics official pulls the plug on the KIACTA™ AA amyloidosis program. We have ...

ADC Therapeutics raises $105M

Oncology company ADC Therapeutics S.a.r.l. (Lausanne, Switzerland) raised $105 million in an oversubscribed round from existing investors Auven Therapeutics Management LLLP (St. Thomas, Virgin Islands...

Drugs and Medications [0 Results]


Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Beat AML Core Study

In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity assays will be utilized to define clinically relevant gene mutations and identify potential ther...

Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

The purpose of this study is to investigate a novel thermosensitive topical gel formulation for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis.

Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study

Prospective, single-arm, open label, Safety and Performance clinical investigation.

A Gene Transfer Study for Hemophilia A

This clinical research study is being conducted by Spark Therapeutics, Inc. to determine the safety and efficacy of the factor VIII gene transfer treatment with SPK-8011 in individuals wit...

Companies [10 Associated Companies listed on BioPortfolio]

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. ...

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. ...

Antegrin Therapeutics, Inc.

Antegrin Therapeutics, Inc., is a pharmaceutical company dedicated to developing novel treatments for fibrotic diseases. The company aims to select its first clinical development ...

Constance Therapeutics

Constance Therapeutics is a vertically integrated medicinal cannabis company producing standardized and science-based whole plant cannabis extracts. The company has created a new ...

venBio Select Advisor LLC

venBio Select Advisor LLC (“venBio Select”) is the SEC registered investment manager for venBio’s public markets strategy and its main equity investment vehicle â...

More Information about "Auven Therapeutics" on BioPortfolio

We have published hundreds of Auven Therapeutics news stories on BioPortfolio along with dozens of Auven Therapeutics Clinical Trials and PubMed Articles about Auven Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Auven Therapeutics Companies in our database. You can also find out about relevant Auven Therapeutics Drugs and Medications on this site too.

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Corporate Database Quicklinks

Searches Linking to this Company Record